Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precise Treatment for Children With Acute Promyelocytic Leukemia
ChiCTR-OPC-16009670Phase 4Recruiting
- Sponsor
- Shanghai Children's Hospital
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of arsenic trioxide in Acute promyelocytic leukaemia (APL) (2 arms), sponsored by Shanghai Children's Hospital. Primary endpoints: Overall survival, Event-free survival and 2 more. Started Nov 2016; status: recruiting.
02
Drugs
arsenic trioxide
03
Conditions
Acute promyelocytic leukaemia (APL)
Beyond the preview
Go deeper on ChiCTR-OPC-16009670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16009670.